We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
With several pieces of legislation being considered to lower drug spending costs, lawmakers and industry sources see opportunities to overhaul federal healthcare policy to improve the generic drug industry.